64-47-1
中文名稱
硫酸依色林
英文名稱
ESERINE SULFATE
CAS
64-47-1
EINECS 編號(hào)
200-585-4
分子式
C30H44N6O8S
MDL 編號(hào)
MFCD06795853
分子量
648.77
MOL 文件
64-47-1.mol
64-47-1 結(jié)構(gòu)式
基本信息
中文別名
硫酸毒豆堿硫酸依色林
毒扁豆堿硫酸鹽
依色林硫酸鹽
英文別名
(3AS)-CIS-1,2,3,3A,8,8A-HEXAHYDRO-1,3A,8-TRIMETHYLPYRROLO[2,3-B]INDOL-5-OL METHYLCARBAMATE HEMISULFATEESERINE HEMISULFATE
ESERINE HEMISULFATE SALT
ESERINE SULFATE
PHYSOSTIGMINE HEMISULFATE
PHYSOSTIGMINE HEMISULFATE SALT
PHYSOSTIGMINE SULFATE
(3as-cis)-amate(estersulfate(2:1)(salt)
(3as-cis)-ylcarbamate(estersulfate(2:1)
3-b)indole,1,2,3,3a,8,8a-hexahydro-5-hydroxy-1,3a,8-trimethyl-pyrrolo(meth
eserinesulphate
physostigmineso4
physostigminesulphate
Pyrrolo2,3-bindol-5-ol, 1,2,3,3a,8,8a-hexahydro-1,3a,8-trimethyl-, methylcarbamate (ester), (3aS,8aR)-, sulfate (2:1) (salt)
PHYSOSOTIGMINESULPHATE
Physostigminsulfat
(3aS-cis)-1,2,3,3a,8,8a-Hexahydro-1,3a,8-trimethylpyrrolo[2,3-b]indol-5-ol methylcarbamate hemisulfate
物理化學(xué)性質(zhì)
熔點(diǎn)140° (after drying at 100°)
密度1.0911 (rough estimate)
折射率1.7000 (estimate)
儲(chǔ)存條件2-8°C
儲(chǔ)存條件2-8°C
溶解度DMSO（微溶）、乙醇（微溶）、甲醇（微溶）
形態(tài)粉末
顏色White to off-white
水溶解性溶于水至100mM
Merck13,7469
穩(wěn)定性吸濕性
CAS 數(shù)據(jù)庫(kù)64-47-1(CAS DataBase Reference)
EPA化學(xué)物質(zhì)信息Physostigmine sulfate (2:1) (64-47-1)
安全數(shù)據(jù)
警示詞危險(xiǎn)
危險(xiǎn)性描述H300+H330
防范說(shuō)明P260-P264-P284-P301+P310-P310
危險(xiǎn)品標(biāo)志T+
危險(xiǎn)類別碼26/28
危險(xiǎn)類別碼R26/28
安全說(shuō)明25-45
安全說(shuō)明S25-S45
危險(xiǎn)品運(yùn)輸編號(hào)UN 2811 6.1/PG 1
危險(xiǎn)品運(yùn)輸編號(hào)UN 2811 6.1/PG 1
WGK Germany3
WGK Germany3
RTECS號(hào)UY8585000
F8-21
危險(xiǎn)等級(jí)6.1(a)
包裝類別II
常見(jiàn)問(wèn)題列表
生物活性
Physostigmine hemisulfate (Eserine hemisulfate) 是一種可逆的乙酰膽堿酯酶 (AChE) 抑制劑。Physostigmine hemisulfate 可以透過(guò)血腦屏障并刺激中樞膽堿能神經(jīng)傳遞。Physostigmine hemisulfate 能逆轉(zhuǎn)阿爾茨海默病轉(zhuǎn)基因小鼠的記憶缺陷。Physostigmine hemisulfate 也是抗膽堿能中毒的解毒劑。體內(nèi)研究
Physostigmine hemisulfate (Eserine hemisulfate; 0.03-0.3 mg/kg; s.c.; daily for 6 weeks) improves deficits in contextual and cued memory in Tg(+) mice.
Physostigmine hemisulfate (IV; 0.1, 0.2 mg/kg) delays time to emergence from isoflurane anesthesia at doses ≥0.2 mg/kg in male Sprague-Dawley rats.
| Animal Model: | Heterozygous transgenic mice (Tg(+) mice) |
| Dosage: | 0.03, 0.1, and 0.3 mg/kg |
| Administration: | SC; daily for 6 weeks |
| Result: | Tended to normalize the contextual memory deficit in Tg(+) animals so that they became more similar to Tg(-) animals. |